Table 1

Diagnostic accuracy data reported by included studies

Author, yearNon-TP, TP testT+veF+veF−veT−veTotalSensitivity (95% CI)
Specificity (95% CI)
PPV (95% CI)
NPV (95% CI)
Syphilis prevalence (%)
Benzaken et al 27 2011VDRL, FTA-Abs assuming missing VDRL, n=8 test +ve511369371262.5% (24.5% to 91.5%)
98.4% (97.2% to 99.2%)
31.3% (11.0% to 58.7%)
99.6% (98.7% to 99.9%)
8/712 (1.12)
Assuming missing VDRL, n=6 test −ve412269471266.7% (22.3% to 95.7%)
98.3% (97.0% to 99.1%)
25.0% (7.3% to 52.4%)
99.7% (99.0% to 100.0%)
6/812 (0.84)
Bronzan et al 28 2007
Before training on how to properly obtain fingerstick blood
RPR, TPHA31461360569570.0% (56.0% to 0.82%)
92.9% (91.0% to 95.0%)
40.3% (29% to 52%)
97.9% (96% to 99%)
44/695 (6.33)
After training2022929034190.9%
90.9%
40.8%
99.3%
22/341 (6.5)
Kashyap et al 31 2015VDRL, TPHA30119620075.0% (95% CI NR)
100.0%
100%
99.45% (95% CI NR)
4/200 (2.0)
Montoya et al 29 2006RPR, TPHA326131553974448686.0% (82.1% to 89.3%)
96.8% (96.2% to 97.3%)
71.0% (66.6% to 75.1%)
98.7% (98.3% to 99.0%)
381/4486 (8.5)
Tinajeros et al 30 2006RPR, TPPA314128288422889291.8% (88.4% to 94.5%)
98.5% (98.2% to 98.8%)
71.0% (66.6% to 75.2%)
99.7% (99.5% to 99.8%)
342/8892 (3.8)
  • F+ve, false positive; F− ve, false negative; FTA-Abs, fluorescent treponemal antibody absorbed; Non-TP, non-treponemal; NPV, negative predictive value; NR, not registered; PPV, positive predictive value; RPR, rapid plasma reagin; T+ve, true positive; T-ve, true negative; TP, treponemal; TPHA, Treponema pallidum  haemagglutination test; TPPA; Treponema pallidum particle agglutination; VDRL, Venereal Disease Research Laboratory.